SEC Form 4 · accession 0000899243-17-024070
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Kenny
Officer — Chief Executive Officer · Director
Period of report
Oct 9, 2017
Accepted (ET)
Oct 11, 2017 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 9, 2017 | A | 13,000 | $0.00 | A | 13,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $14.50 | Oct 9, 2017 | A | 100,000 | A | — | Oct 9, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1These Restricted Stock units vest in full on October 9, 2019.
- F2These options vest in four equal annual installments from the date of grant (i.e., 25% per year until fully vested on October 9, 2021).